NEW YORK, Feb. 13 - Compugen said on Wednesday that Vincent Zurawski, CEO of its US subsidiary and president of the company's Novel Genomics Division, will be leaving the firm in mid-March.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic link between birth weight and adult-onset diseases, and more.
Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.
DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.
Researchers discuss the need for antibody standards at a meeting, NPR reports.